Last reviewed · How we verify
NCT06316882: ROGCAS
Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program
trial testing Screening endoscopy in Gastric Cancer in 349 participants. Completed in 24 February 2025.
24 February 2025
Quick facts
| Lead sponsor | Unidade Local De Saúde Do Norte Alentejano |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 349 |
| Start date | 3 February 2023 |
| Primary completion | 24 February 2025 |
| Estimated completion | 24 February 2025 |
| Sites | 1 location across Portugal |
Drugs / interventions tested
- Screening endoscopy
Conditions studied
- Gastric Cancer — all drugs for Gastric Cancer →
- Gastric (Stomach) Cancer — all drugs for Gastric (Stomach) Cancer →
- Atrophic Gastritis — all drugs for Atrophic Gastritis →
- Intestinal Metaplasia of Gastric Mucosa — all drugs for Intestinal Metaplasia of Gastric Mucosa →
Sponsor
Unidade Local De Saúde Do Norte Alentejano
Who can join
40 and older, any sex, with Gastric Cancer or Gastric (Stomach) Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Endoscopic screening of gastric cancer combined with screening colonoscopy
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Gastric Cancer Endoscopic Screening in an Intermediate-Risk Country-A Dual-Center Pilot Program.
Mourato MB, Pratas N, Branco Pereira A, Costa Pinto F, et al · · 2025 · cited 1× · PMID 40762368 · DOI 10.1111/hel.70061
Verify or expand the search:
- PubMed search for NCT06316882
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastric Cancer
Currently open trials in the same condition.
- NCT07525765 — AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer · recruiting
- NCT07464470 — Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers · recruiting
- NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
- NCT07431281 — Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta · Phase 3 · recruiting
- NCT07448493 — Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer · active not recruiting
Other Unidade Local De Saúde Do Norte Alentejano trials
Trials by the same sponsor.
- NCT07522320 — Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management · active not recruiting
- NCT07387237 — Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06316882 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unidade Local De Saúde Do Norte Alentejano
- Last refreshed: 27 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06316882.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing